INDIVIDUAL SUSCEPTIBILITY AND PREVENTION OF OCCUPATIONAL-DISEASES - SCIENTIFIC AND ETHICAL ISSUES

被引:39
作者
VANDAMME, K
CASTELEYN, L
HESELTINE, E
HUICI, A
SORSA, M
VANLAREBEKE, N
VINEIS, P
机构
[1] UNIV ANTWERP,DEPT EPIDEMIOL & COMMUNITY MED,B-2020 ANTWERP,BELGIUM
[2] UNIV LEUVEN,CTR HUMAN GENET,LOUVAIN,BELGIUM
[3] COMMUN SCI ST LEON SUR VEZERE,ST LEON VEZERE,FRANCE
[4] INST NACL SEGURIDAD & HIGIENE TRABAJO,CTR NACL CONDICIONES TRABAJO,BARCELONA,SPAIN
[5] FINNISH INST OCCUPAT HLTH,HELSINKI,FINLAND
[6] STATE UNIV GHENT,EXPTL CANCEROL LAB,B-9000 GHENT,BELGIUM
[7] UNIV TURIN,DIPARTIMENTO SCI BIOMED & ONCOL UMANA,TURIN,ITALY
关键词
D O I
10.1097/00043764-199501000-00013
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Genetic testing of employees is controversial; objections have been raised with regard to privacy, right to work, and the relevance of the tests, A study is being conducted on ''the ethical, social, and scientific problems related to the application of genetic screening and genetic monitoring for employees in the context of a European approach to health and safety at work.'' A conceptual model is proposed of the complex interactions between exposure, acquired and inherited susceptibility, and risk for disease, The validity of tests for determining genotype and phenotype and their relevance for disease must be evaluated critically to provide an objective basis for ethical discussions. The acceptability of such tests is related to a number of issues, which are identified and discussed.
引用
收藏
页码:91 / 99
页数:9
相关论文
共 30 条
[1]  
AHLBORN A, 1984, INTRO MODERN EPIDEMI, P26
[2]  
ASHFORD NA, 1992, MONITORING WORKER EX
[3]   RELEVANCE OF METABOLIC POLYMORPHISMS TO HUMAN CARCINOGENESIS - EVALUATION OF EPIDEMIOLOGIC EVIDENCE [J].
CAPORASO, N ;
LANDI, MT ;
VINEIS, P .
PHARMACOGENETICS, 1991, 1 (01) :4-19
[4]  
CARTWRIGHT RA, 1982, LANCET, V2, P842
[5]  
CHOLERTON S, 1993, LANCET, V343, P62
[6]   GENETIC ALTERATIONS IN BLADDER-CANCER [J].
DALBAGNI, G ;
PRESTI, J ;
REUTER, V ;
FAIR, WR ;
CORDONCARDO, C .
LANCET, 1993, 342 (8869) :469-471
[7]  
DEKORT WLA, 1993, PERSONNEL SELECTION
[8]   THE ASSOCIATION OF THE SLOW ACETYLATOR PHENOTYPE WITH BLADDER-CANCER [J].
EVANS, DAP ;
EZE, LC ;
WHIBLEY, EJ .
JOURNAL OF MEDICAL GENETICS, 1983, 20 (05) :330-333
[9]  
HAGMAR L, 1994, CANCER RES, V54, P2919
[10]  
HANSSEN HP, 1985, EUR UROL, V11, P263